MOTS-c and mitochondria: what the 2026 literature actually says
A friendly tour through a peptide that gets a lot of hype but limited human data.
by Editorial team
What MOTS-c is
MOTS-c is a 16-amino-acid peptide encoded inside mitochondrial DNA — unusual, since most peptides are encoded in the cell nucleus. It was first described in 2015 and has since become a popular subject in metabolism and longevity research.
What current research suggests
Animal studies suggest MOTS-c may improve insulin sensitivity, support mitochondrial efficiency under stress, and help regulate metabolism in aging tissues.
Early human work is mostly observational. Lower circulating MOTS-c levels correlate with insulin resistance and aging-related metabolic decline, but causation has not been established in people.
Where the hype outpaces the data
Marketing language around MOTS-c often invokes 'energy,' 'longevity,' or 'mitochondrial reset.' Those concepts come from animal-model interpretations, not from controlled human outcomes.
No long-term human dosing studies exist yet for injected MOTS-c. Safety, ideal dose, and even ideal delivery method remain open questions.